Efficacy of the Use of 3D Printing Models in the Treatment of Tibial Plateau Fractures: a Randomi… (NCT05571449) | Clinical Trial Compass
UnknownNot Applicable
Efficacy of the Use of 3D Printing Models in the Treatment of Tibial Plateau Fractures: a Randomized Clinical Trial
Spain30 participantsStarted 2022-10-01
Plain-language summary
TIBIA3D is a randomized, open and prospective clinical trail that evaluates the use of preoperative 3D printing in the surgical treatment of patients with tibial plateau fractures
Who can participate
Age range18 Years – 99 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with tibial plateau fracture requiring surgical treatment.
* Age equal to or greater than 18 years.
* Signature of informed consent in writing according to current legislation before collecting any information.
Exclusion Criteria:
* Pregnancy in progress.
* Presence of serious systemic pathology or another situation that contraindicates treatment
* Presence of other fractures in the ipsilateral femur or tibia that condition the surgical treatment of the tibial plateau fracture.
* Findings in the physical examination, in the results of the tests or other medical, social or psychopathological factors that, in the opinion of the investigators, could negatively influence the study.
* Inability to grant informed consent in the absence of a legal representative.
* Inability to follow instructions or collaborate during the development of the study.